NASDAQ: RNAZTranscode Therapeutics Inc Stock Ownership - Who owns Transcode Therapeutics?
Insider buying vs selling
Have Transcode Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Thomas A. Fitzgerald | Chief Financial Officer | 2023-09-28 | 49,350 | $0.51 | $25.17kBuy |
| Robert Michael Dudley | Chief Executive Officer | 2023-09-28 | 98,000 | $0.51 | $49.98kBuy |
| Robert Michael Dudley | Chief Executive Officer | 2023-06-21 | 12,000 | $2.65 | $31.81kBuy |
| Robert Michael Dudley | Chief Executive Officer | 2023-06-20 | 6,607 | $2.55 | $16.85kBuy |
| Robert Michael Dudley | Chief Executive Officer | 2023-06-09 | 19,000 | $2.76 | $52.44kBuy |
| Robert Michael Dudley | Chief Executive Officer | 2023-06-09 | 19,000 | $2.76 | $52.44kBuy |
| Robert Michael Dudley | Chief Executive Officer | 2023-06-09 | 19,000 | $2.76 | $52.44kBuy |
RNAZ insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RNAZ insiders and whales buy or sell their stock.
RNAZ Shareholders
What type of owners hold Transcode Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Anna Moore | 26.74% | 1,552,785 | $753.10k | Insider |
| Zdravka Medarova | 26.74% | 1,552,785 | $753.10k | Insider |
| Citadel Advisors LLC | 4.85% | 281,908 | $136.73k | Institution |
| Renaissance Technologies LLC | 3.23% | 187,400 | $90.89k | Institution |
| Robert Michael Dudley | 3.10% | 180,262 | $87.43k | Insider |
| Philippe Calais | 2.19% | 127,377 | $61.78k | Insider |
| Private Capital Management LLC | 1.39% | 80,704 | $39.14k | Institution |
| Thomas A. Fitzgerald | 0.97% | 56,318 | $27.31k | Insider |
| Geode Capital Management LLC | 0.90% | 52,232 | $25.33k | Institution |
| Captrust Financial Advisors | 0.86% | 50,000 | $24.25k | Institution |
RNAZ vs Biotech Stocks
Transcode Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.